Home › Obesity › Texas › San Antonio
Pag-aaral pangklinika para sa Obesity sa San Antonio, TX
Isang pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa San Antonio. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- Kailera Clinical Site, San Antonio
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Nagre-recruitPhase 3
- DM Clinical, San Antonio
- The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research, San Antonio
- at 1 pa
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Nagre-recruitPhase 1
- Endeavor Clinical Trials, San Antonio
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Nagre-recruitPhase 3
- Sleep Therapy Research Center, San Antonio
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Nagre-recruitPhase 3
- VIP Trials, San Antonio
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Nagre-recruitPhase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Nagre-recruitPhase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
- IMA Clinical Research San Antonio, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Nagre-recruitPhase 3
- IMA Clinical Research San Antonio, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Nagre-recruitPhase 3
- Research Site, San Antonio
- Research Site, San Antonio
- Research Site, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Nagre-recruitPhase 3
- Sleep Therapy Research Center, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Nagre-recruitPhase 3
- Bandera Family Health Care, San Antonio
- Consano Clinical Research - Shavano Park, Shavano Park · 12 mi ang layo
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Nagre-recruitPhase 3
- IMA Clinical Research San Antonio, San Antonio
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Nagre-recruitPhase 3
- VIP Trials, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Nagre-recruitPhase 2
- Endeavor Clinical Trials, San Antonio
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 3
- AURORA-1 Clinical Site, San Antonio
- AURORA-1 Clinical Site, San Antonio
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, San Antonio
- AURORA-2 Clinical Site, San Antonio
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Nagre-recruitPhase 3
- Pinnacle Clinical Research - San Antonio, San Antonio
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Nagre-recruitPhase 2
- Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Nagre-recruitPhase 3
- Pinnacle Clinical Research - South San Antonio, San Antonio
- IMA Clinical Research - San Antonio, San Antonio
- Consano Clinical Research, Shavano Park · 12 mi ang layo
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Nagre-recruitPhase 3
- Sleep Therapy Research Center, San Antonio
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- ACCOMPLISH-2 Research Site, San Antonio
- ACCOMPLISH-2 Research Site, San Antonio
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Nagre-recruitPhase 3
- Sleep Therapy Research Center, San Antonio
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Nagre-recruitPhase 2
- Endeavor Clinical Trials, San Antonio
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Nagre-recruitPhase 2
- Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- ICON, San Antonio
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Nagre-recruitPhase 4
- Texas Dermatology and Laser Specialists, San Antonio
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Nagre-recruitPhase 3
- Clinical Trials of Texas, San Antonio
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Nagre-recruitPhase 3
- Kailera Clinical Site, San Antonio
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- ICON Early Phase Services, LLC, San Antonio
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Nagre-recruitPhase 3
- VIP Trials, San Antonio
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- ICON Early Phase Services, San Antonio
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Nagre-recruitPhase 3
- University Hospital, San Antonio
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Nagre-recruitPhase 3
- ACCOMPLISH-1 Research Site, San Antonio
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Nagre-recruitPhase 2
- Flourish Research - San Antonio Medical Trials, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 12 mi ang layo
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Nagre-recruitPhase 3
- VIP Trials_San Antonio, San Antonio
Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- South Texas Health Care System, San Antonio, TX, San Antonio
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- Vanda Investigational Site, San Antonio
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
Nagre-recruitPhase 2
- University of Texas Health Science Center at San Antonio, San Antonio
Pag-aaral para sa Obesity sa ibang lungsod
- Houston, TX43 pag-aaral
- Chicago, IL41 pag-aaral
- New York City, NY40 pag-aaral
- Washington, DC33 pag-aaral
- Orlando, FL31 pag-aaral
- Dallas, TX30 pag-aaral
- Boston, MA28 pag-aaral
- Las Vegas, NV27 pag-aaral
- Miami, FL27 pag-aaral
- Baltimore, MD25 pag-aaral
- Jacksonville, FL25 pag-aaral
- St. Louis, MO25 pag-aaral
Iba pang pag-aaral sa San Antonio
- Non-Small Cell Lung Cancer59 pag-aaral
- Colorectal Cancer46 pag-aaral
- Kanser sa Suso46 pag-aaral
- Metastatic Cancer44 pag-aaral
- Kanser (lahat ng uri)41 pag-aaral
- Type 2 Diabetes37 pag-aaral
- Overweight34 pag-aaral
- Kanser sa Ovary31 pag-aaral
- Kanser sa Pancreas31 pag-aaral
- Kanser sa Prostate28 pag-aaral
- Kanser ng Endometrium27 pag-aaral
- Kanser sa Baga26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.